Maximum atrial tracking rate for cardiac rhythm management system

• US 7,062,323 B2
• Filed: 10/19/2001
• Issued: 06/13/2006
• Est. Priority Date: 10/19/2001
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Spinelli, Julio C., Carlson, Gerrard M., Zhu, Qingsheng
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US10/040,287
• Publication Number:
  US 20030078624A1
• Time in Patent Office: 1,698 Days
• Field of Search: 607/9, 607/14, 607/19, 607/25, 600/528
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/36542 controlled by body motion, e.g. acceleration

Abstract

A cardiac rhythm management system includes an operational mode in which ventricular pacing pulses are delivered at a rate that tracks a sinoatrial rate up to an appropriate maximum atrial tracking rate (MATR) value determined by the system. In one example, the MATR value is based on a patient activity level and a hemodynamic maximum rate (HMR) determined from a QRS-to-S₂ interval, where S₂ is an accelerometer-generated fiducial correlative to aortic valve closure (AVC). In a further example, a correlation between the QRS-to-S₂ interval and heart rate is established, and the MATR is based on the patient activity level and heart rate. In a further example, a lower rate threshold for providing antitachyarrhythmia therapy is modified based on the MATR. For example, when the MATR exceeds a default value of the antitachyarrhythmia therapy lower rate threshold, the threshold tracks the MATR. In another example, the MATR is based on an active time between a QRS complex and a heart impedance signal maximum slope during the same cardiac cycle.

Claims

1. A method including:

detecting one or more atrial depolarizations;

measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator; and

providing ventricular pacing, in response to one or more of the sensed atrial depolarizations, at a ventricular pacing rate that is limited by the maximum atrial tracking rate.

2. The method of claim 1, in which measuring the subinterval includes:

detecting a portion of a QRS complex;

detecting an indication of an aortic valve closure; and

measuring an indication of a time interval between the detected QRS complex and the detected aortic valve closure.

3. The method of claim 2, in which detecting an indication of an aortic valve closure includes detecting an acceleration fiducial correlative to the aortic valve closure.

4. The method of claim 3, in which detecting the acceleration fiducial includes detecting an S2 heart sound.

5. The method of claim 4, in which measuring the indication of the time interval between the detected QRS complex and the detected aortic valve closure includes:

converting a measured time interval between the detected QRS complex and the S2 heart sound into a heart rate; and

adding a rate offset thereto to obtain the indication of the time interval between the detected QRS complex and the detected aortic valve closure.

6. The method of claim 1, in which establishing the maximum atrial tracking rate includes:

providing a base value of the maximum atrial tracking rate;

detecting a present activity level of the patient;

detecting a maximum activity level over a period of time; and

computing the maximum atrial tracking rate by scaling a difference between the hemodynamic maximum rate indicator and the base value of the maximum atrial tracking rate by a ratio of the present activity level to the maximum activity level, and adding the scaled difference to the base value of the maximum atrial tracking rate to establish the maximum atrial tracking rate.

7. The method of claim 1, further including:

providing a first tachyarrhythmia therapy rate threshold; and

adjusting the first tachyarrhythmia therapy rate threshold when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

8. The method of claim 7, in which adjusting the first tachyarrhythmia therapy rate threshold includes substantially equating the first tachyarrhythmia therapy rate threshold to the maximum atrial tracking rate when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

9. The method of claim 1, in which measuring the subinterval of the patient'"'"'s cardiac cycle correlative to the hemodynamic maximum rate indicator is carried out at a plurality of heart rates to create a correlation between heart rate and the hemodynamic maximum rate indicator.

10. The method of claim 9, in which establishing the maximum atrial tracking rate is based at least in part on the correlation between heart rate and the hemodynamic maximum rate indicator.

11. The method of claim 1, further including adjusting a criteria for providing an antitachyarrhythmia therapy based on the established maximum atrial tracking rate.

12. The method of claim 11, further including increasing a rate threshold for providing an antitachyarrhythmia therapy to a value that is greater than or equal to the established maximum atrial tracking rate.

13. The method of claim 12, further including increasing a lower rate threshold for a lower antitachyarrhythmia therapy zone to a value that is greater than or equal to the established maximum atrial tracking rate.

14. The method of claim 1, in which establishing the maximum atrial tracking rate includes calculating the maximum atrial tracking rate (MATR) as:

MATR=Default MATR+(HMR−

Default MATR)·

(AL/MAL), where Default MATR is a previously programmed value, HMR is a hemodynamic maximum rate based at least in part on the time interval between the QRS complex and the fiducial, AL is the patient activity level, and MAL is a maximum value of the patient activity level over a preceding time period.

15. The method of claim 1, in which measuring the subinterval includes:

detecting a portion of a QRS complex;

detecting a heart impedance including variations corresponding to heart contractions;

detecting a time associated with a maximum slope of the heart impedance; and

measuring an active time interval between the detected QRS complex and the time associated with the maximum slope of the heart impedance occurring during the same cardiac cycle as the detected QRS complex.

16. The method of claim 15, in which establishing the maximum atrial tracing rate includes using a rate corresponding to the active time interval.

17. A method including:

measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator;

providing a first tachyarrhythmia therapy rate threshold; and

adjusting the first tachyarrhythmia therapy rate threshold when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

18. The method of claim 17, in which adjusting the first tachyarrhythmia therapy rate threshold includes substantially equating the first tachyarrhythmia therapy rate threshold to the maximum atrial tracking rate when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

19. A method including:

measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator; and

increasing a rate threshold for providing an antitachyarrhythmia therapy to a value that is greater than or equal to the established maximum atrial tracking rate.

20. The method of claim 19, further including increasing a lower rate threshold for a lower antitachyarrhythmia therapy zone to a value that is greater than or equal to the established maximum atrial tracking rate.

21. A system including:

means for measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

means for establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator;

means for providing a first tachyarrhythmia therapy rate threshold; and

means for adjusting the first tachyarrhythmia therapy rate threshold when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

22. The system of claim 21, in which the means for adjusting the first tachyarrhythmia therapy rate threshold includes means for substantially equating the first tachyarrhythmia therapy rate threshold to the maximum atrial tracking rate when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

23. A system including:

means for measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

means for establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator; and

means for increasing a rate threshold for providing an antitachyarrhythmia therapy to a value that is greater than or equal to the established maximum atrial tracking rate.

24. The system of claim 23, further including means for increasing a lower rate threshold for a lower antitachyarrhythmia therapy zone to a value that is greater than or equal to the established maximum atrial tracking rate.

25. A method including:

measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator;

adjusting a criteria for providing an antitachyarrhythmia therapy based on the established maximum atrial tracking rate; and

providing an antitachyarrhythmia therapy in response to a detected tachyarrhythmia using the adjusted criteria for providing the antitachyarrhythmia therapy.

26. The method of claim 25, including increasing a rate threshold for providing an antitachyarrhythmia therapy to a value that is greater than or equal to the established maximum atrial tracking rate.

27. A system including:

means for measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

means for establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator;

means for adjusting a criteria for providing an antitachyarrhythmia therapy based on the established maximum atrial tracking rate; and

means for providing an antitachyarrhythmia therapy in response to a detected tachyarrhythmia using the adjusted criteria for providing the antitachyarrhythmia therapy.

28. The system of claim 27, including means for increasing a rate threshold for providing the antitachyarrhythmia therapy to a value that is greater than or equal to the established maximum atrial tracking rate.

29. A system including:

means for detecting one or more atrial depolarizations;

means for measuring a subinterval of a patient'"'"'s cardiac cycle to obtain a hemodynamic maximum rate indicator;

means for establishing a maximum atrial tracking rate based at least in part on the hemodynamic maximum rate indicator; and

means for providing ventricular pacing, in response to one or more of the sensed atrial depolarizations, at a ventricular pacing rate that is limited by the maximum atrial tracking rate.

30. The system of claim 29, in which the means for measuring the sub interval includes:

means for detecting a portion of a QRS complex;

means for detecting an indication of an aortic valve closure; and

means for measuring an indication of a time interval between the detected QRS complex and the detected aortic valve closure.

31. The system of claim 30, in which the means for detecting an indication of an aortic valve closure includes means for detecting an acceleration fiducial correlative to the aortic valve closure.

32. The system of claim 31, in which the means for detecting the acceleration fiducial includes means for detecting an S2 heart sound.

33. The system of claim 32, in which the means for measuring the indication of the time interval between the detected QRS complex and the detected aortic valve closure includes:

means for converting a measured time interval between the detected QRS complex and the S2 heart sound into a heart rate; and

means for adding a rate offset thereto to obtain the indication of the time interval between the detected QRS complex and the detected aortic valve closure.

34. The system of claim 29, in which the means for establishing the maximum atrial tracking rate includes:

means for providing a base value of the maximum atrial tracking rate;

means for detecting a present activity level of the patient;

means for detecting a maximum activity level over a period of time; and

means for computing the maximum atrial tracking rate by scaling a difference between the hemodynamic maximum rate indicator and the base value of the maximum atrial tracking rate by a ratio of the present activity level to the maximum activity level, and adding the scaled difference to the base value of the maximum atrial tracking rate to establish the maximum atrial tracking rate.

35. The system of claim 29, further including:

means for providing a first tachyarrhythmia therapy rate threshold; and

means for adjusting the first tachyarrhythmia therapy rate threshold when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

36. The system of claim 35, in which the means for adjusting the first tachyarrhythmia therapy rate threshold includes means for substantially equating the first tachyarrhythmia therapy rate threshold to the maximum atrial tracking rate when the maximum atrial tracking rate exceeds the first tachyarrhythmia therapy rate threshold.

37. The system of claim 29, in which the means for measuring the subinterval of the patient'"'"'s cardiac cycle correlative to the hemodynamic maximum rate indicator includes means for carrying out the measuring at a plurality of heart rates to create a correlation between heart rate and the hemodynamic maximum rate indicator.

38. The system of claim 37, in which means for establishing the maximum atrial tracking rate includes means for establishing the maximum atrial tracking rate based at least in part on the correlation between heart rate and the hemodynamic maximum rate indicator.

39. The system of claim 29, further including means for adjusting a criteria for providing an antitachyarrhythmia therapy based on the established maximum atrial tracking rate.

40. The system of claim 39, further including means for increasing a rate threshold for providing an antitachyarrhythmia therapy to a value that is greater than or equal to the established maximum atrial tracking rate.

41. The system of claim 40, further including means for increasing a lower rate threshold for a lower antitachyarrhythmia therapy zone to a value that is greater than or equal to the established maximum atrial tracking rate.

42. The system of claim 29, in which establishing the maximum atrial tracking rate includes calculating the maximum atrial tracking rate (MATR) as:

MATR=Default MATR+(HMR−

Default MATR)·

(AL/MAL), where Default MATR is a previously programmed value, HMR is a hemodynamic maximum rate based at least in part on the time interval between the QRS complex and the fiducial, AL is the patient activity level, and MAL is a maximum value of the patient activity level over a preceding time period.